The PHARMIGA consortium has been awarded a multi-million euro investment to build a national research network focused on developing medicines based on IgA antibodies.

Lightbridge Corporation (NASDAQ:LTBR) Q4 2025 Earnings Call Transcript February 26, 2026 Operator: Thank you for standing by, and welcome to the Lightbridge Corporation business update and fiscal year ...

Wheelchair-accessible rides for residents with disabilities through zTrip Subsidized Uber rides for able-bodied people ...

AI-enhanced vision systems automate medical device quality control, replacing manual inspection with flexible solutions.

The drug was finally approved in September 2025 through the FDA’s accelerated approval pathway, based on improvement in knee extensor muscle strength, for adults and children with Barth syndrome who ...